Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 5,619Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Alcon Canada Inc.

02 2Gowling WLG (Canada) LLP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Olopatadine Hydrochloride

Brand Name : PATANOL

Patent Number : 1337603

Filing Date : 1990-08-02

Strength per Unit : 0.1%

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Ophthalmic (topical)

Patent Expiration Date : 2012-11-21

Date Granted : 1995-11-21

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Olopatadine Hydrochloride

Brand Name : PATANOL

Patent Number : 2195094

Filing Date : 1996-05-03

Strength per Unit : 0.1%

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Ophthalmic (topical)

Patent Expiration Date : 2016-05-03

Date Granted : 2002-02-26

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Olopatadine Hydrochloride

Brand Name : PATADAY

Patent Number : 1337603

Filing Date : 1987-03-03

Strength per Unit : 0.2%

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Ophthalmic

Patent Expiration Date : 2012-11-21

Date Granted : 1995-11-21

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Olopatadine Hydrochloride

Brand Name : PATADAY

Patent Number : 2195094

Filing Date : 1996-05-03

Strength per Unit : 0.2%

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Ophthalmic

Patent Expiration Date : 2016-05-03

Date Granted : 2002-02-26

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Olopatadine Hydrochloride

Brand Name : PATADAY

Patent Number : 2447924

Filing Date : 2002-06-19

Strength per Unit : 0.2%

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Ophthalmic

Patent Expiration Date : 2022-06-19

Date Granted : 2009-11-03

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Olopatadine Hydrochloride

Brand Name : PAZEO

Patent Number : 2826725

Filing Date : 2012-05-18

Strength per Unit : 0.7% w / v

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : OPHTHALMIC

Patent Expiration Date : 2032-05-18

Date Granted : 2016-11-01

blank